| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 707055 | Null | 0.0222343516878695 | 0.16777557 |
| NSC 756619 | Null | 0.0222343516878695 | 0.08271932 |
| NSC 112152 | 2H,4aH-1,4,5-Trioxadicyclopent[a,hi]indene-7-carboxylic acid, 3-ethylidene-3,3a,7a,9b-tetrahydro-2-oxo-, methyl ester, [3aS-(3E,3a.alpha.,4a.beta.,7a.beta.,9aR*,9b.beta.)]- (9CI) | 0.0222343516878698 | -0.017347364 |
| NSC 180198 | Hydrazinecarbothioamide, 2,2'-(1,5-dimethyl-1,5-pentanediylidene)bis[N-methyl- | 0.0222343516878698 | 0.023426052 |
| NSC 363812 | Tetraplatin | 0.0222343516878698 | 0.5178386 |
| NSC 633203 | Null | 0.0222343516878698 | 0.070229767 |
| NSC 634471 | Null | 0.0222343516878698 | 0.0025607514 |
| NSC 682756 | Spiro[4H-1-benzazepine-4,1'-cyclohexane]-2,5(1H,3H)-dione, 4'-(4-chlorophenyl)-3'-[(4-chlorophenyl)carbonyl]- 4'-hydroxy- | 0.0222343516878698 | 0.31637101 |
| NSC 117915 | 1H-Indole-2,3-dione, 5-methyl-,3-[2-(2-nitrophenyl)hydrazone] | 0.0244632509325736 | 0.033763213 |
| NSC 150862 | BLEOMYCIN FRACTION BLM-HPE | 0.0244632509325736 | 0.51067819 |